IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa
This study is currently recruiting participants.
Verified February 2017 by Nadine Tung, MD, Dana-Farber Cancer Institute
Sponsor:
Beth Israel Deaconess Medical Center
Information provided by (Responsible Party):
Nadine Tung, MD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01670500
First received: August 16, 2012
Last updated: February 4, 2017
Last verified: February 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | June 2018 |
| Estimated Primary Completion Date: | June 2018 (Final data collection date for primary outcome measure) |